These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 331285)

  • 1. [Levamisole--an attempt at immunomodulating treatment of inflammatory and autoimmune nervous system diseases].
    Cendrowski W
    Pol Tyg Lek; 1977 Aug; 32(31):1211-3. PubMed ID: 331285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various aspects of the mechanism of action of levamisole].
    Chumakova MM
    Ter Arkh; 1978; 50(9):146-53. PubMed ID: 360467
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL
    Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].
    Mukhtarova AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levamisole -- a drug modifying immunologic phenomena].
    Bogdanikowa B
    Postepy Hig Med Dosw; 1979; 33(2):125-46. PubMed ID: 384382
    [No Abstract]   [Full Text] [Related]  

  • 6. Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases.
    Verhaegen H; De Cree J; De Cock W; Verbruggen F
    Clin Exp Immunol; 1977 Feb; 27(2):313-8. PubMed ID: 321165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunomodulating effect of levamisole in animal experiments].
    Sikorska H
    Reumatologia; 1979; 17(3):339-47. PubMed ID: 390660
    [No Abstract]   [Full Text] [Related]  

  • 8. Levamisole in neurological diseases: a preliminary report.
    Gentile A; Fasanaro AM; Mazza C; Pannone B; Scoleri G
    Acta Neurol (Napoli); 1978 Aug; 33(4):365-70. PubMed ID: 742448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Targets and mechanisms of levamisole-induced immunostimulation (author's transl)].
    Renoux G; Renoux M
    Nouv Presse Med; 1978 Jan; 7(3):197-201. PubMed ID: 307228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in chronic inflammatory diseases.
    Wilton JM
    J Rheumatol Suppl; 1978; 4():101-13. PubMed ID: 366135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of immunoregulation in autoimmune syndromes].
    Skotnicki AB
    Postepy Hig Med Dosw; 1983; 37(4):345-87. PubMed ID: 6233544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Levamisole treatment in ataxia telangiectasis].
    Kubiczek K; Lankosz-Lauterbach J; Zybaczyński J
    Pol Tyg Lek; 1979 Sep; 34(37):1465-6. PubMed ID: 503951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunomodulator in the study of rheumatoid arthritis (author's transl)].
    Abe S
    Ryumachi; 1978 Dec; 18(6):381-4. PubMed ID: 375429
    [No Abstract]   [Full Text] [Related]  

  • 14. Levamisole therapy in ataxia-telangiectasia.
    Levendoğlu O; Berkel AI; Ersoy F; Sanal O
    Turk J Pediatr; 1981; 23(4):255-9. PubMed ID: 7345701
    [No Abstract]   [Full Text] [Related]  

  • 15. Potassium channels, memory T cells, and multiple sclerosis.
    Beeton C; Chandy KG
    Neuroscientist; 2005 Dec; 11(6):550-62. PubMed ID: 16282596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of levamisole for correcting the immunological reactivity disorders in autoimmune cytopenias].
    Tishchenko LM
    Vrach Delo; 1981 Sep; (9):73-7. PubMed ID: 7197847
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term trial of levamisole on ataxia-telangiectasia: effect on the immunological and clinical parameters.
    Battistella PA; Argentiero V; Bizzarini M; Tavolato B
    Acta Neurol (Napoli); 1984 Aug; 6(4):290-9. PubMed ID: 6485907
    [No Abstract]   [Full Text] [Related]  

  • 19. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D; Sela M; Arnon R
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlations of clinical and laboratory effects of treatment with levamisole in autoimmune disease.
    Levy J
    Cancer Treat Rep; 1978 Nov; 62(11):1715-9. PubMed ID: 365326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.